Skip to content

Managing Anxiety From Cancer (MAC): Testing an Intervention for Anxiety in Older Adults With Cancer and Their Caregivers

Managing Anxiety From Cancer (MAC): A Pilot Randomized Controlled Trial of a Psychological Intervention for Anxiety in Older Adults With Cancer and Their Caregivers

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03168971
Enrollment
26
Registered
2017-05-30
Start date
2019-01-23
Completion date
2025-10-27
Last updated
2025-10-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anxiety, Depression, Quality of Life

Keywords

Cancer, Anxiety, Cognitive behavior therapy, Elderly, Caregivers, 18-542

Brief summary

This study is being done to test the effects of Managing Anxiety from Cancer (MAC) therapy on anxiety compared to usual care, in patients and their caregivers. MAC is different from usual care because it uses a plan for managing anxiety that has been shown to work in previous studies. MAC has designed this plan for people 65 years of age and older. MAC also includes the primary caregiver which has been shown to help patients manage their anxiety.

Interventions

The intervention consists of seven telephone-administered sessions. Session topics include psychoeducation on anxiety, behavioral strategies for managing anxiety, cognitive restructuring, communication skills training, acceptance techniques, problem-solving strategies, and planning for future anxiety. Session content is tailored for older adults and caregivers of older adults with cancer.

Sponsors

Weill Medical College of Cornell University
CollaboratorOTHER
National Institute on Aging (NIA)
CollaboratorNIH
Memorial Sloan Kettering Cancer Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Intervention model description

Patient-caregiver dyads will be randomly assigned to the intervention or a usual care control condition.

Eligibility

Sex/Gender
ALL
Age
21 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

PATIENTS: * Age 65 or older * Confirmed diagnosis of breast, lymphoma, genitourinary, thoracic, gynecological or gastrointestinal cancer, currently on active treatment or within six months of completion of treatment * As determined by the patient's primary oncologist and/or study staff, physically and cognitively able to complete study procedures * English fluent (as per self-reported fluency of very well)\*\* * In the judgment of the investigators and/or consenting professional, able to perform informed consent * Has a primary informal caregiver (as defined by an unpaid individual who provides the patient with emotional, physical, and/or practical support) who is willing and able to participate in the study * As part of the patient-caregiver dyad, at least one member reports elevated anxiety as defined by a score of 8 or greater on the anxiety subscale of the Hospital Anxiety and Depression Scale (HADS) * As per self-report, residency in New York or ability to complete sessions in New York * Able to communicate over the phone for sessions * Willingness to be audio-recorded for assessments and, if applicable, study sessions CAREGIVERS: * Age 21 or older * In the judgment of the investigators and/or consenting professional, able to perform informed consent * As part of the patient-caregiver dyad, at least one member reports elevated anxiety as defined by a score of 8 or greater on the anxiety subscale of the Hospital Anxiety and Depression Scale (HADS) * English fluent (as per self-reported fluency of very well)\*\* * Is a primary informal caregiver (as defined by an unpaid individual who provides the patient with emotional, physical, and/or practical support) for an MSK patient * As per self-report, residency in New York or ability to complete sessions in New York * Able to communicate over the phone for sessions * Willingness to be audio-recorded for assessments and, if applicable, study sessions

Exclusion criteria

PATIENTS: * Endorsing active suicidal ideation on the item, In light of your current circumstances, have you ever had thoughts of killing yourself? * As per oncologist or self-report, too weak or cognitively impaired to participate in the intervention and complete the assessments * Per self-report/screening measures, has received cognitive-behavioral therapy since cancer diagnosis * As per medical record or self-report, currently being treated for schizophrenia, substance use or dependence, and/or bi-polar disorder * Anxiety due solely to a medical procedure as determined by a patient-report item on the screening questionnaire CAREGIVERS: * Endorsing active suicidal ideation on the item, In light of your current circumstances, have you ever had thoughts of killing yourself? * Per self-report/screening measures, has received cognitive-behavioral therapy since patients cancer diagnosis * As per self-report, currently being treated for schizophrenia, substance use or dependence, and/or bi-polar disorder * If female, currently pregnant

Design outcomes

Primary

MeasureTime frameDescription
Anxiety sub-scale of the Hospital Anxiety and Depression ScaleBaseline (1-2 weeks after enrollment) and Follow-up (7-9 weeks after baseline)Change in anxiety from baseline to follow-up
Hamilton Anxiety Rating ScaleBaseline (1-2 weeks after enrollment) and Follow-up (7-9 weeks after baseline)Change in anxiety from baseline to follow-up

Secondary

MeasureTime frameDescription
Functional Assessment of Cancer Therapy-General: Emotional Quality of Life Sub-Scale (patients only)Baseline (1-2 weeks after enrollment) and Follow-up (7-9 weeks after baseline)Change in health-related quality of life
Depression sub-scale of the Hospital Anxiety and Depression ScaleBaseline (1-2 weeks after enrollment) and Follow-up (7-9 weeks after baseline)Change in depression from baseline to follow-up
Montgomery-Asberg Depression ScaleBaseline (1-2 weeks after enrollment) and Follow-up (7-9 weeks after baseline)Change in depression from baseline to follow-up
Caregiver Quality of Life-Cancer (caregivers only)Baseline (1-2 weeks after enrollment) and Follow-up (7-9 weeks after baseline)Change in health-related quality of life
Distress ThermometerBaseline (1-2 weeks after enrollment) and Follow-up (7-9 weeks after baseline)Change in distress from baseline to follow-up

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026